Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients

NCT04352465 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Methotrexate
DRUG: Methotrexate
DRUG: Methotrexate

Sponsor

Azidus Brasil

Collaborators

[object Object]
[object Object]
[object Object]